Qin Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qin Lu has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Dong-Sheng Zhou
Department of Psychiatry, Ningbo Kangning Hospital, Ningbo, Zhejiang Province 315201, China
1 shared publicationDong-Ying Xu
Department of Obstetrics and Gynecology, TongRen Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China
1 shared publication- Haibo Cai
State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, PR China
1 shared publication Jingyun Li
Department of Clinical Laboratory, Nanjing Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
1 shared publicationLi Ma
Department of Neurology, Jingzhou Central Hospital, Jingzhou, Hubei Province 434020, China
1 shared publicationPei Hu
Department of Vasculocardiology, Jingzhou Central Hospital, Jingzhou, Hubei Province 434020, China
1 shared publication
Latest Publications
- 19 June 2018
- Published by Elsevier in Process Biochemistry
- Vol. 72, 143-151
Hyperoside promotes ex vivo expansion of hematopoietic stem/progenitor cells derived from cord blood by reducing intracellular ROS level
- 19 June 2018
- Published by Elsevier in Process Biochemistry
- Vol. 72, 143-151
Hyperoside promotes ex vivo expansion of hematopoietic stem/progenitor cells derived from cord blood by reducing intracellular ROS level
- Open Access
- 22 February 2016
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 37 (4) , 931-938
MicroRNA-29a induces insulin resistance by targeting PPARδ in skeletal muscle cells
Intrauterine growth retardation (IUGR) induces metabolic syndrome, which is often characterized by insulin resistance (IR), in adults. Previous research has shown that microRNAs (miRNAs or miRs) play a role in the target genes involved in this process, but the mechanisms remain unclear. In the present study, we examined miRNA profiles using samples of skeletal muscles from both IUGR and control rat offspring whose mothers were fed either a protein-restricted diet or a diet which involved normal amounts of protein during pregnancy, respectively. miR‑29a was found to be upregulated in the skeletal muscles of IUGR offspring. The luciferase reporter assay confirmed the direct interaction between miR‑29a and peroxisome proliferator‑activated receptor δ (PPARδ). Overexpression of miR‑29a in the skeletal muscle cell line C2C12 suppressed the expression of its target gene PPARδ, which, in turn, influenced the expression of its coactivator, peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α). Thus, PPARδ/PGC-1α‑dependent signals together reduced insulin-dependent glucose uptake and adenosine triphosphate (ATP) production. Overexpression of miR‑29a also caused a decrease in levels of glucose transporter 4 (GLUT4), the most important glucose transporter in skeletal muscle, which partially induced a decrease insulin‑dependent glucose uptake. These findings provide evidence for a novel micro-RNA‑mediated mechanism of PPARδ regulation, and we also noted the IR-promoting actions of miR-29a in skeletal muscles of IUGR.
- 22 February 2016
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 37 (4) , 931-938
Open AccessMicroRNA-29a induces insulin resistance by targeting PPARδ in skeletal muscle cells
Intrauterine growth retardation (IUGR) induces metabolic syndrome, which is often characterized by insulin resistance (IR), in adults. Previous research has shown that microRNAs (miRNAs or miRs) play a role in the target genes involved in this process, but the mechanisms remain unclear. In the present study, we examined miRNA profiles using samples of skeletal muscles from both IUGR and control rat offspring whose mothers were fed either a protein-restricted diet or a diet which involved normal amounts of protein during pregnancy, respectively. miR‑29a was found to be upregulated in the skeletal muscles of IUGR offspring. The luciferase reporter assay confirmed the direct interaction between miR‑29a and peroxisome proliferator‑activated receptor δ (PPARδ). Overexpression of miR‑29a in the skeletal muscle cell line C2C12 suppressed the expression of its target gene PPARδ, which, in turn, influenced the expression of its coactivator, peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α). Thus, PPARδ/PGC-1α‑dependent signals together reduced insulin-dependent glucose uptake and adenosine triphosphate (ATP) production. Overexpression of miR‑29a also caused a decrease in levels of glucose transporter 4 (GLUT4), the most important glucose transporter in skeletal muscle, which partially induced a decrease insulin‑dependent glucose uptake. These findings provide evidence for a novel micro-RNA‑mediated mechanism of PPARδ regulation, and we also noted the IR-promoting actions of miR-29a in skeletal muscles of IUGR.
- 1 November 2015
- Published by Elsevier in European Journal of Pharmacology
- Vol. 767, 183-192
Secoisolariciresinol diglycoside, a flaxseed lignan, exerts analgesic effects in a mouse model of type 1 diabetes: Engagement of antioxidant mechanism
- 1 November 2015
- Published by Elsevier in European Journal of Pharmacology
- Vol. 767, 183-192
Secoisolariciresinol diglycoside, a flaxseed lignan, exerts analgesic effects in a mouse model of type 1 diabetes: Engagement of antioxidant mechanism